Trial reportEuropean journal of nutrition2026
Investigating enhancement of learning and memory following supplementation with Juice Plus
Trial report in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05581108 (Enhancement of Learning and Memory Following Supplementation With Juice PLUS+® OMEGA in an Adolescent Population), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Enhancement of Learning and Memory Following Supplementation With Juice PLUS+® OMEGA in an Adolescent Population
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOmega fatty acids (FA) have been shown to benefit cognition during infancy and adulthood. However, adolescence remains under investigated, despite being a critical period for development of executive functions and emotion regulation. The current objective was to investigate the impact of daily treatment with a proprietary omega-FA blend on cognitive performance, mood, and emotion regulation in healthy adolescents aged 13-14 years.
methodsUsing a parallel, double-blind, placebo controlled design, participants were randomly allocated to consume the omega blend (2 capsules/day providing 925 mg blend of algae-derived omega 3-, 7-, and 9-FAs) or a placebo (2 capsules/day of MCT oil) for 16 weeks. Episodic memory, executive function, mood, emotion regulation, EEG measures, and omega-3 index (O3I) were recorded at baseline and following 16 weeks of intervention.
resultsO3I increased significantly only in the omega blend group, indicating compliance with the intervention and improved O3I status. Improvements were observed for immediate word recall and delayed word recall aspects of episodic memory in the omega blend group only. Significantly faster reaction times were also observed on an attention network executive function task in the omega group. Alongside cognitive benefits, changes in EEG activity were observed, including increased N200 ERP deflections during 0-back task performance, and reduced PSD activity during sustained attention and at rest.
conclusionCombined, these cognitive and physiological findings suggest that an omega-FA blend may support cognitive development in healthy adolescents aged 13 & 14, potentially through facilitation of brain maturation and more efficient allocation of neural resources. CLINICAL TRIAL NUMBER: ClinicalTrials.gov ID: NCT05581108. Registration date: 11/10/2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.